Unicycive Therapeutics Inc (UNCY)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $97.25M
Last updated: Nov 17, 2026 at 4:43 PM ET
Unicycive Therapeutics Inc (UNCY) Stock Chart
Unicycive Therapeutics (UNCY) has a latest price of $3.70 on Nov 17, 2026, 57.7% below its 52-week high of $8.74. Its price fell 34.7% over the past 12 months. The month-end price fell 87.1% over the 5 years through Oct 2026, a compound annual decline of 33.6%.
Price Chart
From Jul 2021 to Oct 2026, its highest month-end close was $29.00 in Aug 2021 and its lowest $3.38 in Aug 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart UNCY with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for UNCY.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 33.7%, and over 6 months it fell 52.1%. The month-end price fell 34.4% over the 3 years through Oct 2026, a compound annual decline of 13.1%.
| Period | Change |
|---|---|
| 1 month | +5.4% |
| 3 months | -33.7% |
| 6 months | -52.1% |
| 12 months | -34.7% |
| 12 months, with dividends | -34.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -34.4% | -13.1% |
| 5 years | -87.1% | -33.6% |
Price by Year
Its best calendar year was 2023, when the price rose 60.7%, and its weakest was 2022, when it fell 73.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.74 | -35.2% |
| 2025 | $5.77 | -27.3% |
| 2024 | $7.94 | -8.5% |
| 2023 | $8.68 | +60.7% |
| 2022 | $5.40 | -73.8% |
Trading Range
The price is 10.6% below its 50-day average of $4.14 and 37.5% below its 200-day average of $5.92.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.70 | |
| 52-week high | $8.74 | -57.7% |
| 52-week low | $3.33 | +11.1% |
| 50-day average | $4.14 | -10.6% |
| 200-day average | $5.92 | -37.5% |
Price Risk
Over 3 years, its largest fall from a peak was 86.8%.
| Measure | Value |
|---|---|
| 1-year beta | 1.11 |
| Largest fall, 1 year | -60.7% |
| Largest fall, 3 years | -86.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About UNCY
What is UNCY's 1-year price change?
Unicycive Therapeutics's price fell 34.7% over the past 12 months. With dividends included, the 12-month total return was -34.7%.
What is UNCY's 5-year price change?
Unicycive Therapeutics's month-end price fell 87.1% over the 5 years through Oct 2026, a compound annual decline of 33.6%. These figures leave out dividends.
What is UNCY's 52-week high and low?
Unicycive Therapeutics's 52-week high is $8.74 and its 52-week low is $3.33. Its latest price of $3.70 on Nov 17, 2026 is 57.7% below the high.
What is UNCY's beta?
Unicycive Therapeutics's 1-year beta against the S&P 500 is 1.11, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 60.7%.
Is the UNCY chart free?
Yes. Advanced Charting for UNCY is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
UNCY pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors